|
Volumn 17, Issue 8, 2006, Pages 1367-1368
|
Appropriate premedication risk reduction during adrenal ablation [4]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
METIROSINE;
PHENOXYBENZAMINE;
ADRENAL TUMOR;
CATECHOLAMINE RELEASE;
CATHETER ABLATION;
HUMAN;
HYPERTENSIVE CRISIS;
LETTER;
MALIGNANT HYPERTENSION;
PREMEDICATION;
PRIORITY JOURNAL;
RISK REDUCTION;
TACHYCARDIA;
ADRENAL GLAND NEOPLASMS;
ADRENERGIC ALPHA-ANTAGONISTS;
ALPHA-METHYLTYROSINE;
ANTIHYPERTENSIVE AGENTS;
CRYOSURGERY;
ENZYME INHIBITORS;
HUMANS;
HYPERTENSION, MALIGNANT;
PHENOXYBENZAMINE;
RADIOGRAPHY, INTERVENTIONAL;
RISK ASSESSMENT;
TYROSINE 3-MONOOXYGENASE;
|
EID: 33747491951
PISSN: 10510443
EISSN: None
Source Type: Journal
DOI: 10.1097/01.RVI.0000234616.35625.6A Document Type: Letter |
Times cited : (12)
|
References (7)
|